Insider · CIK 0001677036
Kevin Robert Lind
ceoofficerdirectorpresident
Files at AVTX (Avalo Therapeutics, Inc.), LBPH (Longboard Pharmaceuticals, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | AVTX Avalo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,352 | $12.29 | $17k | 1,352 | 10 d ago |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | UTender of shares Common Stock | -363,740 | $60.00 | $22M | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -255,377 | - | - | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -192,783 | - | - | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -325,850 | - | - | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -332,134 | - | - | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -22,000 | - | - | 0 | Dec 2, 2024 |
| Nov 13, 2024 | LBPH Longboard Pharmaceuticals, Inc. | MOption exercise Common Stock | +12,808 | $3.12 | $40k | 443,740 | Nov 13, 2024 |
| Nov 13, 2024 | LBPH Longboard Pharmaceuticals, Inc. | GGift Common Stock | -80,000 | $0.00 | $0 | 363,740 | Nov 13, 2024 |
| Nov 13, 2024 | LBPH Longboard Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -12,808 | $0.00 | $0 | 255,377 | Nov 13, 2024 |
| Oct 25, 2024 | LBPH Longboard Pharmaceuticals, Inc. | AGrant or award Retention Restricted Stock Unitsderivative | +22,000 | $0.00 | $0 | 22,000 | Oct 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.